for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Luye Pharma Group Says Clinical Trial Application Of Lurbinected Accepted By CDE Of PRC

June 29 (Reuters) - Luye Pharma Group Ltd:

* CLINICAL TRIAL APPLICATION OF LURBINECTEDIN FOR INJECTION (LY01017) ACCEPTED BY CENTRE FOR DRUG EVALUATION OF PRC Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up